The Intelligence from The Economist Nine out of ten, doctors say: a promising coronavirus vaccine
Nov 10, 2020
Natasha Loder, health policy editor at the Economist, discusses a promising coronavirus vaccine with a 90% efficacy rate, while addressing the regulatory and distribution hurdles ahead. Kinley Salmon, Africa correspondent, dives into the recent tumultuous elections across Guinea, Tanzania, and Ivory Coast, exploring how strongmen manipulate democracy to cling to power. They also touch on India's complicated relationship with cannabis, highlighting the clash between moral campaigns and cultural acceptance.
AI Snips
Chapters
Transcript
Episode notes
Promising Vaccine
- A 90% effective COVID-19 vaccine is a major achievement, exceeding expectations.
- This news brings hope during a difficult year marked by the pandemic.
Vaccine Efficacy
- The new vaccine's 90% efficacy surpasses expectations, offering a potential solution to the crisis.
- Provisional results suggest it's a watershed moment, but more data is needed.
Vaccine Safety
- While the vaccine appears safe in trials so far, long-term effects are unknown.
- More safety data needs to be gathered as it has only been used in tens of thousands of patients for two months.